¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Transitory metabolic disturbance of newborn, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® basal metabolic rate(BMR) ÇÑ±Û ±âÃÊ´ë»çÀ²
¼³¸í   
  Ç¥ÁØ ±âÃÊ´ë»ç·®°ú ºñ±³ÇßÀ» ¶§ °³Ã¼ ±âÃÊ´ë»ç·®ÀÌ º¸À̴ ÆíÂ÷¸¦ Ç¥½ÃÇϴ Áö¼ö. ±âÃÊ´ë»ç·®Àº »ý¸íÀ» À¯ÁöÇϴµ¥ ÇÊ¿äÇÑ ÃÖ¼ÒÇÑÀÇ ¿¡³ÊÁö ´ë»ç·®À̸ç, ¼º°ú ¿¬·ÉÀÌ µ¿ÀÏÇÑ °Ç°­ÀÎÀÇ ±âÃÊ´ë»ç·®Àº Ã¼Ç¥¸éÀû¿¡ ºñ·ÊÇÑ´Ù. À̰ÍÀ» Ã¼Ç¥¸éÀûÀÇ ¹ýÄ¢À̶ó°í Çϸç, 1882³â µ¶ÀÏÀÇ ´ë»ç»ý¸®ÇÐÀÚ M. ºê·ç³Ê¿¡ ÀÇÇØ Á¦Ã¢µÇ¾ú´Ù. Ã¼Ç¥¸éÀûÀº ½ÅÀå°ú Ã¼Áß¿¡ ÀÇÇØ »êÃâµÈ´Ù. µû¶ó¼­ ¼º-¿¬·É-½ÅÀå-üÁßÀ» ¾Ë¸é Ç¥ÁرâÃÊ·® Y°¡ »êÃâµÇ°í ½ÇÁ¦ÀÇ ±âÃÊ´ë»ç·® X´Â »ê¼Ò¼Òºñ·®°ú ÀÌ»êȭź¼Ò ¹ß»ý·®¿¡¼­ »êÃâµÈ´Ù. ±×¸®°í X¿Í YÀÇ Â÷À̸¦ Y·Î ³ª´« °ª(%)À» ±âÃÊ´ë»çÀ²À̶ó°í ÇÑ´Ù. °æÇèÀûÀ¸·Î ¾òÀº BMRÀÇ °£´ÜÇÑ ÃøÁ¤¹ýµµ ÀÖÀ¸¸ç ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇÑ´Ù. ÀÌ ½Ä¿¡¼­ ¸ÆÆøÀ̶õ ÃÖ°íÇ÷¾Ð°ú ÃÖÀúÇ÷¾ÐÀÇ Â÷¸¦ ¸»ÇÑ´Ù. BMR(%)=0.75(1ºÐ ¸Æ¹Ú¼ö + 0.74¡¿¸ÆÆø)£­72. BMRÀÌ 10% À̳»À̸é Á¤»ó¹üÀ§, +10% ÀÌ»óÀ̸頱âÃÊ´ë»çÇ×Áø, £­10% ÀÌÇÏÀ̸頱âÃÊ´ë»ç ÀúÇ϶ó°í ÇÑ´Ù. ±âÃÊ´ë»ç´Â °øº¹½Ã(½ÄÈÄ 10½Ã°£ °æ°ú)¿¡ ¾ÈÁ¤µÈ »óÅ¿¡¼­ ´ÜÀ§ ½Ã°£´ç ÀÌ¿ëµÇ´Â ¿¡³ÊÁöÀÇ ¾ç, Áï, ÇÑ ½Ã°£´ç, ¸ö Ç¥¸éÀÇ 1m2´ç ¶Ç´Â ¸ö¹«°Ô 1kg ´ç Ä®·Î¸®·Î ³ªÅ¸³½´Ù. À̰ÍÀº °³Àο¡ µû¶ó ´Ù¸£¸ç Àå±â°£¿¡´Â °ÅÀÇ º¯È­°¡ ¾øÁö¸¸ Áúº´ µîÀ¸·Î ÀÎÇØ º¯µ¿µÈ´Ù. ½ÇÃøÇÑ ±âÃÊ´ë»ç¸¦ Ç¥ÁØÄ¡¿Í ºñ±³ÇÔÀ¸·Î½á Áúº´ÀÇ Áø´Ü µî¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ´Ù BMR=(½ÇÃøÄ¡-Ç¥ÁØÄ¡)/Ç¥ÁØÄ¡ ¡¿100(%)·Î ³ªÅ¸³½´Ù.
¿µ¹® gait disturbance ÇÑ±Û º¸ÇàÀå¾Ö, °ÉÀ½Àå¾Ö
¼³¸í   
  Á¤»óÀûÀΠ°ÉÀ½°ÉÀ̰¡ ºÒ°¡´ÉÇÑ »óÅÂ. ÁßÃß ½Å°æÀ̳ª ´Ù¸®ÀÇ ±ÙÀ° Àå¾Ö ¶§¹®¿¡ »ý±â´Â °ÍÀ¸·Î ½ÇÁ¶¼º º¸Çà, ¼Ò³ú¼º º¸Çà, ¸¶ºñ¼º º¸Çà, ¾ÆÀ徯À堰ȱ⠵îÀÌ ÀÖ´Ù. ¼ºÀÎÀÇ °æ¿ì¿¡´Â »À-°üÀýÀÇ Áß´ëÇÑ ¿Ü»óÀ̳ª ¸¸¼º·ù¸¶Æ¼½º°üÀýÀ» ºñ·ÔÇÏ¿©, ³úÇ÷°üÀå¾Ö¿¡ ÀÇÇÑ ¹Ý½Å¸¶ºñ, Ã´¼ö¼Õ»ó-ÆÄŲ½¼ÁõÈıº-±ÙÀ°À§Ãà°¡ÂʰæÈ­Áõ µîÀÌ ¿øÀÎÀÌ µÈ´Ù. ¾î¸°ÀÌÀÇ °æ¿ì´Â ½ÉÇÑ Á¤½ÅÁöü-³ú¼º¸¶ºñ-ÁøÇ༺±ÙÀ°À§ÃàÁõ-ÁøÇ༺±ÙÀ°ÅðÇàÀ§Ã࠵ ÀÇÇÑ °ÍÀÌ ÀÖ´Ù. ÇѶ§´Â ¼±Ãµ¼º ¾ûµ¢°üÀýÅ»±¸¿¡ ÀÇÇÑ º¸ÇàÀå¾Ö¸¦ º¼ ¼ö ÀÖ¾úÀ¸³ª, ¿äÁò¿¡´Â Á¶±âÁø´Ü-Á¶±âÄ¡·á·Î °ÅÀÇ º¼¼ö ¾ø´Ù.
¿µ¹® newborn infant ÇÑ±Û ½Å»ý¾Æ
¼³¸í   
  ºÐ¸¸ Á÷ÈĺÎÅÍ µ¶¸³µÈ ÀÚ±ÃÀÇ »ýȰÀ» ÇÒ ¼ö Àִ ´É·ÂÀ» È¹µæÇÒ ¶§±îÁöÀÇ ¾ÆÀÌ. ½Å»ý¾Æ´Â »ýÈÄ 4ÁÖÀϱîÁö¸¦ ¸»ÇÑ´Ù. ÀÌ ±â°£¿¡ ½Å»ý¾Æ´Â ¸ðüÀÇ Å ¾È¿¡¼­ ÀÚµ¿ÀûÀ¸·Î »ê¼Ò³ª ¿µ¾çÀ» ¹Þ°í ÀÖ´ø »óÅ¿¡¼­ ÀÚ·ÂÀ¸·Î È£ÈíÀ̳ª ¿µ¾ç ¼·Ã븦 ÇϰԠµÇ´Â ±Þ°ÝÇÑ º¯È­°¡ ÀϾ°í, ÀÌ¿¡ µû¶ó¼­ ÃʱâÀǠü¿ÂÀÇ °­ÇÏ, »ý¸®Àû Ã¼ÁßÀÇ °¨¼Ò, ½Å»ý¾ÆÈ²´Þ, ÅÈÁÙÀÇ Å»¶ô µîÀÇ ¿©·¯ Çö»óÀÌ ÀϾ´Ù. °¨°¢¸é¿¡¼­´Â ¿µ¾ç ¼·Ã븦 À§ÇÑ ÈíÀιݻç´Â Àß ¹ß´ÞµÇ¾î ÀÖÀ¸³ª, ¹Ì°¢Àº ´ë°­ÀÇ ¸ÀÀÇ ÆÇº°, Èİ¢Àº °­ÇÑ ¾ÇÃë¿¡ ´ëÇÑ ¹ÝÀÀ, ½Ã°¢Àº ¸í¾ÏÀ» ÆÇº°Çϴ Á¤µµÀ̸ç, Ã»°¢Àº »ýÈÄ 1ÁÖÀϰæ±îÁö´Â °ÅÀÇ ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â´Ù.
¿µ¹® hemolytic disease of newborn ÇÑ±Û ½Å»ý¾Æ¿ëÇ÷º´
¼³¸í   
  ½Å»ý¾Æ¿¡¼­ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î Å¾ÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼­ »ý»êµÈ ½Å»ý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ Å¹ÝÀ» °Ç³Ê¿Í¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼­ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». ÁŻý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼­ »ý»êÀÌ µÇ°í À̰ÍÀ̠ŹÝÀ» ÅëÇØ¼­ Å¾ƿ¡°Ô ³Ñ¾î°¡¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼­ ºóÇ÷ÀÌ »ý±ä °ÍÀ» Å¾ÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´­ ¼ö°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • newborn
    ½Å»ý¾Æ
  • newborn baby
    ½Å»ý¾Æ
  • newborn behavior assessment scale
    ½Å»ý¾ÆÇൿÆò°¡Ã´µµ
  • newborn infant
    ½Å»ý¾Æ
  • association disturbance
    ¿¬»óÀå¾Ö
  • autonomic disturbance
    ÀÚÀ²½Å°æÀå¾Ö
  • dissociated sensory disturbance
    ÇØ¸®°¨°¢Àå¾Ö
  • disturbance
    Àå¾Ö, ±³¶õ
  • disturbance of attention
    ÁÖÀÇ·ÂÀå¾Ö
  • extrapyramidal motor disturbance
    ÇǶó¹Ìµå¹Ù±ù±æ¿îµ¿Àå¾Ö, Ãßü¿Ü·Î¿îµ¿Àå¾Ö
  • ejaculatory disturbance
    »çÁ¤Àå¾Ö
  • electrolyte disturbance
    ÀüÇØÁúÀå¾Ö
  • emotional disturbance
    °¨Á¤Àå¾Ö
  • gait disturbance
    º¸ÇàÀå¾Ö, °ÉÀ½Àå¾Ö
  • gastrointestinal disturbance
    À§Ã¢ÀÚÀå¾Ö, À§ÀåÀå¾Ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • newborn
    ½Å»ý¾Æ
  • metabolic acidosis
    ´ë»ç»êÁõ
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • metabolic
    ´ë»ç-
  • metabolic pathway
    ´ë»ç°æ·Î
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • metabolic turnover
    ´ë»çÀüȯ
  • disturbance of attention
    ÁÖÀÇ·ÂÀå¾Ö
  • disturbance
    Àå¾Ö, ±³¶õ
  • atrioventricular conduction disturbance
    ¹æ½ÇÀüµµÀå¾Ö
  • autonomic disturbance
    ÀÚÀ²½Å°æÀå¾Ö
  • intellectual disturbance
    Áö´ÉÀå¾Ö
  • orientation disturbance
    Áö³²·ÂÀå¾Ö, ¹æÇâ°¨Àå¾Ö
  • reflex disturbance
    ¹Ý»çÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • newborn metabolic disturbance
    ½Å»ý¾Æ´ë»çÀå¾Ö
  • transitory fiber
    ÀÌÇ༶À¯
  • transitory hydrocele
    Àϰú¼º¹°À½³¶Á¾
  • transitory paralysis
    Àϰú¼º¸¶ºñ
  • newborn baby
    ½Å»ý¾Æ
  • newborn infant
    ½Å»ý¾Æ
  • newborn
    ½Å»ý¾Æ
  • newborn behavior assessment scale
    ¿µ¾ÆÇൿÆò°¡Ã´µµ
  • association disturbance
    ¿¬»óÀå¾Ö
  • atrioventricular conduction disturbance
    ¹æ½ÇÀüµµÀå¾Ö
  • autonomic disturbance
    ÀÚÀ²½Å°æÀå¾Ö
  • disturbance
    Àå¾Ö, ±³¶õ
  • dissociated sensory disturbance
    ÇØ¸®°¨°¢Àå¾Ö
  • ejaculatory disturbance
    »çÁ¤Àå¾Ö
  • electrolyte disturbance
    ÀüÇØÁúÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • BMR=£¾basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • porphyrin metabolic disorder
    Æ÷¸£ÇǸ°´ë»çÀå¾Ö
  • relative metabolic rate
    »ó´ëÀû ´ë»çÀ².
  • anoxic disturbance
    ¹«»ê¼Ò¼º Àå¾Ö.
  • hearing disturbance
    û·ÂÀå¾Ö
  • hemodynamic disturbance
    Ç÷Ç࿪ÇÐÀû Àå¾Ö.
  • postictal disturbance of cerebral function
    ¹ßÀÛÈÄ´ë³ú±â´ÉÀå¾Ö(Û¡íÂý­ÓÞÒà ѦÒöî¡äô).
  • ABO hemolytic disease of the newborn
    ½Å»ý¾Æ ABO ¿ëÇ÷¼ºÁúȯ
  • IRDNI=£¾idiopathic respiratory distress of the newborn infant
    ½Å»ý¾Æ Ư¹ß¼º È£Èí°ï¶õÁõ, À¯¸®Áú¸·Áõ.
  • hemolytic disease of fetus/newborn
    žÆ/½Å»ý¾Æ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemolytic disease of newborn
    ½Å»ý¾Æ ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemorrhagic disease of newborn
    ½Å»ý¾ÆÃâÇ÷(¼º) Áúȯ.
  • idiopathic respiratory distress of newborn infant =IRDNI
    ½Å»ý¾ÆÆ¯¹ß¼º È£Èí°ï¶õÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic disturbance, newborn
    ½Å»ý¾Æ´ë»çÀå¾Ö(ãæßæä®ÓÛÞóî¡äô).
  • transitory fever of newborn
    ½Å»ý¾Æ(ãæßæä®)Àϰú¼º¿­.
  • transitory fever of newborn
    ½Å»ý¾Æ(ãæßæä®)Àϰú¼º¿­
  • paralysis, transitory
    Àϰú¼º¸¶ºñ
  • transitory carrier
    Àϰú¼º º¸±ÕÀÚ(ÊÙËÓË»Ëö).
  • transitory fever
    Àϰú¼º ¿­(¡­æð)
  • transitory fiber
    ÀÌÇ༶À¯
  • transitory hydrocele
  • transitory paralysis
    Àϰú¼º¸¶ºñ
  • transitory postepileptic paralysis
    °£ÁúÈÄÀϰú¼º¸¶ºñ(ÊÖòðý­ìéΦàõ Ýö).
  • epidemic diarrhea of newborn
    ½Å»ý¾Æ(ãæßæä®) À¯Ç༺ ¼³»ç.
  • epidemic diarrhea of newborn
    ½Å»ý¾Æ(ËàË×Ëâ) À¯Ç༺ ¼³»ç.
  • hemolytic disease of fetus/newborn
    žÆ/½Å»ý¾Æ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemolytic disease of newborn
    ½Å»ý¾Æ ¿ëÇ÷¼º Áúȯ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Transitory fiber
    ÀÌÇ༶À¯
    [¿¾ ¿ë¾î] ÀÌÇàºÎ¼¶À¯
  • Metabolic defect of minerals (Asiderosis)
    ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
    [¿¾ ¿ë¾î] ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
  • Metabolic defect of pigment (Methemoglobinemia)
    »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
    [¿¾ ¿ë¾î] »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
  • Congenital metabolic defect
    ¼±Ãµ´ë»ç°áÇÔ
    [¿¾ ¿ë¾î] ¼±Ãµ¼º´ë»ç¼º°áÇÔ
  • Metabolic defect of steroid (Adrenogenital syndrome)
    ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
    [¿¾ ¿ë¾î] ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
  • Metabolic defect of amino acid (Alkaptonuria)
    ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
    [¿¾ ¿ë¾î] ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
  • Metabolic defect of carbohydrate (Galactosemia)
    ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
    [¿¾ ¿ë¾î] ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
  • Metabolic defect of nucleic acid (Purinemia)
    ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
    [¿¾ ¿ë¾î] ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic antigen
    ´ë»çÇ׿ø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transitory complex
    õÀ̺¹ÇÕü(ôÃì¹ÜÜùêô÷)
  • basal metabolic rate
    "±â(ÃÊ,º»)´ë»çÀ²(Ðñ(õ¨,Üâ)ÓÛÞóëÒ)"
  • branched metabolic pathway
    ºÐÁö´ë»ç°æ·Î(ÝÂò«ÓÛÞóÌèÖØ)
  • central metabolic pathway
    ÁßÃß´ë»ç°æ·Î(ñéõÒÓÛÞóÌèÖØ)
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • hyperchloremic metabolic acidosis
    °ú(Φ)¿°¼ÒÇ÷(ç¤áÈúì) ´ë»ç»êÁõ(ÓÛÞóß«ñø)
  • layered metabolic pathway
    Ãþ´ë»ç°æ·Î(öµÓÛÞóÌèÖØ)
  • linear metabolic pathway
    ¼±Çü ´ë»ç°æ·Î(àÊû¡ÓÛÞóÌèÖØ)
  • metabolic acidosis
    ´ë»ç¼º»êÁõ(ÓÛÞóàõß«ñø)
  • metabolic alkalosis
    ´ë»ç¼º(ÓÛÞóàõ)¾ËÄ«¸®Áõ(ñø)
  • metabolic antagonist
    ´ë»ç¼º ±æÇ×Á¦(ÓÛÞóàõÑÏùòð¥))
  • metabolic balance
    ´ë»ç ±ÕÇü(ÓÛÞóгû¬)
  • metabolic block
    ´ë»ç Â÷´Ü(ÓÛÞóó´Ó¨)
  • metabolic bypass
    ´ë»ç Ãø·Î(ÓÛÞóö°ÖØ)
  • metabolic depression
    ´ë»ç ¾ï¾Ð(ÓÛÞóåääâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transitory
    ÀÌÇàÀÇ
  • newborn
    ½Å»ýÀÇ, ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • newborn infant
    ½Å»ý¾Æ
  • disturbance
    Àå¾Ö
  • hearing disturbance
    û·ÂÀå¾Ö
  • orientation disturbance
    ¹æÇâ°¨°¢Àå¾Ö
  • respiratory disturbance
    È£ÈíÀå¾Ö
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • metabolic
    ´ë»ç¼ºÀÇ
  • metabolic acidosis
    ´ë»ç¼º»êÁõ, ´ë»ç¼º¾Æ½Ãµµ½Ã½º
  • metabolic alkalosis
    ´ë»ç¼º¾ËÄ®¸®Áõ
  • metabolic disease
    ´ë»ç¼ºÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • metabolic rate
    ´ë»çÀ²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
STANDOUT soft thresholding and depth cueing of unspecified techniques
URD unspecified respiratory disease; upper respiratory disease
HD   1) Hodgkin's Disease
  2) Hemo-Dialysis
  3) High Density
&...
RDI Respiratory Disturbance Index
ABD abdomen; aged, blind, and disabled; aggressive behavioral disturbance; average body dose
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TIA transitory ischaemic attack
RDI Respiratory Disturbance Index
TMJDS Temporomandibular Joint Disturbance Syndrome
SED serious emotional disturbance
HDN Haemolytic disease of the newborn
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • P74.9
    Transitory metabolic disturbance of newborn, unspecified
    »ó¼¼ºÒ¸íÀÇ ½Å»ý¾ÆÀÇ Àϰú¼º ´ë»ç Àå¾Ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • unspecified
    ºñƯÀ̼º
    ´Ù¸¥ °ÍÇÏ°í¸¸ Ưº°È÷ °áÇÕÀ» ÇÑ´ÙµçÁö ¹ÝÀÀÇϴ ƯÀ̼ºÀÌ ¾ø´Â.
  • transitory carrier
    Àϰú¼º º¸±ÕÀÚ
  • transitory paralysis
    Àϰú¼º ¸¶ºñ
  • epidemic diarrhea of the newborn
    ½Å»ý¾Æ À¯Ç༺ ¼³»çÁõ
  • newborn infant
    ½Å»ý¾Æ
  • period of newborn
    ½Å»ý¾Æ±â
  • basal metabolic rate
    ±âÃÊ ´ë»çÀ²
    ½Ä»ç ÈÄ ÀÏÁ¤ ½Ã°£ÀÌ Áö³ª°í ³ª¼­ÀÇ ¾ÈÁ¤ »óÅ¿¡¼­ÀÇ »ê¼Ò ¼Òºñ ¼Óµµ.
  • metabolic
    ´ë»ç¼ºÀÇ
  • metabolic acidosis
    ´ë»ç¼º »êÁõ, ´ë»ç¼º ¾Æ½Ãµµ½Ã½º
    ÁÖ¿ä ÁöÇ¥´Â È£Èí¼º ¾ËÄ®¸®Áõ¿¡¼­ º¸´Â ¹Ù¿Í °°ÀÌ Áßź»ê ÀÌ¿ÂÀÇ °¨¼ÒÀÌ´Ù. ±×·¯³ª ÀÌ µÎ Àå¾ÖÀÇ »êµµ´Â ´Ù¸£´Ù. ´ë»ç¼º »êÁõÀÇ ¿øÀÎÀº À½ À̿ Â÷À̸¦ °è»êÇÏ´Â °ÍÀÌ À¯¿ëÇÏ´Ù. Áõ»óÀº ÁÖ·Î ±âÁ¸ ÁúȯÀÇ Áõ»óÀÌ´Ù. º¸»óÀû °úȯ±â´Â Áß¿äÇÑ ÀÓ»óÀû ¡ÈÄÀÌ°í ¿ø¹ß¼º È£ÈíÀå¾Ö·Î À߸ø ÇØ¼®µÇ¾î Áú ¼ö ÀÖ´Ù.
  • metabolic alkalosis
    ´ë»ç¼º ¾ËÄ®¸®Áõ, ´ë»ç¼º ¾ËÄ®·Î½Ã½º
    ½ÅüÀÇ »ê-¿°±â ÆòÇüÀÌ ¾ËÄ®¸®ÀÇ ÃàÀû ¶Ç´Â ºñź»ê °íÁ¤, »êÀÇ »ó½Ç¿¡ ÀÇÇÏ¿© ¾ËÄ®¸® ÃøÀ¸·Î ÀÌÇàµÇ´Â Àå¾Ö.
  • metabolic antagonist
    ´ë»ç ±æÇ×Á¦
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metabolic defect of pigment
    »ö¼Ò ´ë»ç °áÇÔ
  • metabolic disease
    ´ë»ç¼º Áúȯ
    ½Åü ¼¼Æ÷ÀÇ È­ÇйÝÀÀÀÇ Àå¾Ö°¡ ¿øÀÎÀÌ µÇ´Â Áúȯ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
transitory Marked by the quality of passing away: evanescent, transient, of brief duration: existing momentarily: temporary.
(18 Nov 1997)
disturbance Deviation from, interruption of, or interference with a normal state.
(05 Mar 2000)
emotional disturbance See: mental illness, behaviour disorder.
(05 Mar 2000)
ABO haemolytic disease of the newborn Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes.
(05 Mar 2000)
bullous impetigo of newborn Usually, widely disseminated bullous lesions appearing soon after birth, caused by infection with Staphylococcus aureus.
Synonym: impetigo neonatorum, pemphigus gangrenosus.
(05 Mar 2000)
respiratory distress syndrome of the newborn A disease seen especially in premature neonates with respiratory distress; characterised postmortem by atelectasis and alveolar ducts lined by an eosinophilic membrane; also associated with reduced amounts of lung surfactant.
Synonym: hyaline membrane syndrome, respiratory distress syndrome of the newborn.
(05 Mar 2000)
pleural effusion in newborn <radiology> Chylothorax most common cause of large effusion, erythroblastosis foetalis, Turner syndrome, congestive heart failure, infantile polycystic kidneys, wet-lung disease, hypervolaemia (idiopathic or iatrogenic), oesophageal tear, enteric cyst, obstructed pulmonary veins
(12 Dec 1998)
congenital epulis of newborn A congenital benign nodular tumour of the alveolar ridge, of unknown histogenesis; histologically, it is composed of large cells with a granular cytoplasm similar to that of a granular cell tumour (myoblastoma).
(05 Mar 2000)
postnatal pit of the newborn It marks the site where the embryonic spinal cord attaches to the skin.
Synonym: postnatal pit of the newborn.
(05 Mar 2000)
haemolytic anaemia of newborn <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
haemolytic disease of newborn <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
haemolytic disease of the newborn Abnormal breakup of red blood cells in the foetus or newborn. This is usually due to antibodies made by the mother directed against the baby's red cells. It is typically caused by rh incompatibility, that is differences between the mother and baby uinvolving the rh blood group.
(12 Dec 1998)
haemorrhagic disease of newborn A self-limited haemorrhagic disorder of the first days of life, caused by a deficiency of the vitamin k-dependent blood coagulation factors II, vii, ix, and x.
(12 Dec 1998)
haemorrhagic disease of the newborn A syndrome characterised by spontaneous internal or external bleeding accompanied by hypoprothrombinaemia, slightly decreased platelets, and markedly elevated bleeding and clotting times, usually occurring between the third and sixth days of life and effectively treated with vitamin K.
(05 Mar 2000)
hyaline membrane disease of the newborn A disease seen especially in premature neonates with respiratory distress; characterised postmortem by atelectasis and alveolar ducts lined by an eosinophilic membrane; also associated with reduced amounts of lung surfactant.
Synonym: hyaline membrane syndrome, respiratory distress syndrome of the newborn.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic
    (½ÅÁø)´ë»çÀÇ
  • unspecified
    Ư±â
  • disturbance
    ±ú¶ß¸®±â
  • newborn
    °«³­
  • transitory
    ¼ø½Ä°£ÀÇ; ¹«»óÇÑ
  • disturbance
    ¼Òµ¿;¹æÇع°;ºÒ¾È
  • newborn
    °«(¹æ±Ý)ž;½Å»ýÀÇ;´Ù½Ã ž;¸¶À½À» °íÃĸÔÀº;ºÎȰÇÑ;½Å»ý¾Æ \
  • transitory
    ÀϽÃÀÇ;ÀϽÃÀûÀÎ;¿À·¡°¡Áö ¾Ê´Â;µ¡¾ø´Â;¹«»óÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á